CASI Pharmaceuticals Inc (NASDAQ:CASI)
| 1.62 Delayed Data As of Mar 24 |  0.00 / 0.00%Today’s Change | 1.45 Today|||52-Week Range 10.30 | -9.50% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 47.7K | 0.00 | 0.00 | 0.00 | |
| Cost of Goods Sold | 6.3K | 0.00 | 0.00 | 0.00 | ||
| Depreciation And Amortization | 68.4K | 66.5K | 117.8K | 1.7M | ||
| Operating Expenses | Gross Income | -26.9K | -66.5K | -117.8K | -1.7M | |
| General Expenses | 7.1M | 9.4M | 10.6M | 24.8M | ||
| Research And Development | 4.1M | 4.6M | 7.6M | 7.2M | ||
| Total Operating Expenses | 7.2M | 9.4M | 10.8M | 26.5M | ||
| Non-Operating Expenses | Operating Income | -7.2M | -9.4M | -10.8M | -26.5M | |
| Extraordinary Credit | 27.5K | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | -6.8K | -19.9K | -1.0M | ||
| Interest Expense On Debt | 82.5K | 33.8K | 15.0K | 8.2K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -7.2M | -9.5M | -10.8M | -27.5M | |
| Net Income | -7.2M | -9.5M | -10.8M | -27.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 32.4M | 55.9M | 61.5M | 84.8M | |
| Shares To Calculate EPS Diluted | 32.4M | 55.9M | 61.5M | 84.8M | ||
| Earnings Per Share | EPS | -$0.22 | -$0.17 | -$0.18 | -$0.32 | |
| EPS Diluted | -$0.22 | -$0.17 | -$0.18 | -$0.32 | ||
